Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.from Top Business News- News18.com https://ift.tt/3a5YNmG
via IFTTT
Saturday, 12 December 2020
AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology
Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.from Top Business News- News18.com https://ift.tt/3a5YNmG
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
Two independent members of the National Statistical Commission had resigned this week after the government allegedly failed to publish the r...
-
Satya Nadella, the company’s third CEO, will also be the third chairman in Microsoft’s history, following Gates and Thompson from Top Busi...
No comments:
Post a Comment